Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Offline impact of transcranial focused ultrasound on cortical activation in primates.

Verhagen L, Gallea C, Folloni D, Constans C, Jensen DE, Ahnine H, Roumazeilles L, Santin M, Ahmed B, Lehericy S, Klein-Flügge MC, Krug K, Mars RB, Rushworth MF, Pouget P, Aubry JF, Sallet J.

Elife. 2019 Feb 12;8. pii: e40541. doi: 10.7554/eLife.40541.

2.

Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.

Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF; APEG Bone Mineral Working Group.

J Paediatr Child Health. 2018 Mar;54(3):223-233. doi: 10.1111/jpc.13768.

PMID:
29504223
3.

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients.

Luo J, Jensen DE, Maroni BJ, Brunelli SM.

Am J Kidney Dis. 2016 Nov;68(5):763-771. doi: 10.1053/j.ajkd.2016.05.031. Epub 2016 Aug 12.

4.

A Randomized Controlled Trial of Two Different Macronutrient Profiles on Weight, Body Composition and Metabolic Parameters in Obese Adolescents Seeking Weight Loss.

Truby H, Baxter K, Ware RS, Jensen DE, Cardinal JW, Warren JM, Daniels L, Davies PS, Barrett P, Blumfield ML, Batch JA.

PLoS One. 2016 Mar 29;11(3):e0151787. doi: 10.1371/journal.pone.0151787. eCollection 2016.

5.

Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.

Luo J, Brunelli SM, Jensen DE, Yang A.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):90-100. doi: 10.2215/CJN.01730215. Epub 2015 Oct 23.

6.

A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.

Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO, Stefánsson BV.

BMC Nephrol. 2015 Jul 22;16:113. doi: 10.1186/s12882-015-0110-9.

7.

Fasting gut hormone levels change with modest weight loss in obese adolescents.

Jensen DE, Nguo K, Baxter KA, Cardinal JW, King NA, Ware RS, Truby H, Batch JA.

Pediatr Obes. 2015 Oct;10(5):380-7. doi: 10.1111/ijpo.275. Epub 2015 Jan 5.

PMID:
25559355
8.

Intradialytic hypotension and risk of cardiovascular disease.

Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2124-32. doi: 10.2215/CJN.02680314. Epub 2014 Nov 6.

9.

Nephrocalcinosis: a potential complication of bisphosphonate therapy in children.

Jensen DE, McGill J, Batch J.

J Paediatr Child Health. 2011 Dec;47(12):929-30. doi: 10.1111/j.1440-1754.2011.02391.x. No abstract available.

PMID:
22171838
10.

Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.

Wood ER, Shewchuk L, Hassel A, Nichols J, Truesdale AT, Smith D, Carter HL, Weaver K, Barrett G, Leesnitzer T, Alvarez E, Bardera AI, Alamillo A, Cantizani J, Martin J, Smith GK, Jensen DE, Xie H, Mook R, Kumar R, Kuntz K.

Biochem Pharmacol. 2009 Dec 15;78(12):1438-47. doi: 10.1016/j.bcp.2009.07.022. Epub 2009 Aug 7.

PMID:
19665448
11.

BAP1, a candidate tumor suppressor protein that interacts with BRCA1.

Jensen DE, Rauscher FJ 3rd.

Ann N Y Acad Sci. 1999;886:191-4. Review. No abstract available.

PMID:
10667217
12.

Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.

Peng H, Begg GE, Schultz DC, Friedman JR, Jensen DE, Speicher DW, Rauscher FJ 3rd.

J Mol Biol. 2000 Feb 4;295(5):1139-62.

PMID:
10653693
13.

Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.

Jensen DE, Rauscher FJ 3rd.

Cancer Lett. 1999 Sep;143 Suppl 1:S13-7. Review. No abstract available.

PMID:
10546591
14.

Nuclear redistribution of BRCA1 during viral infection.

Maul GG, Jensen DE, Ishov AM, Herlyn M, Rauscher FJ 3rd.

Cell Growth Differ. 1998 Sep;9(9):743-55.

15.

S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme.

Jensen DE, Belka GK, Du Bois GC.

Biochem J. 1998 Apr 15;331 ( Pt 2):659-68.

16.

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ 3rd.

Oncogene. 1998 Mar 5;16(9):1097-112.

PMID:
9528852
17.

Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter.

Jensen DE, Black AR, Swick AG, Azizkhan JC.

J Cell Biochem. 1997 Oct 1;67(1):24-31.

PMID:
9328836
18.

Denitrosation of 1,3-dimethyl-2-cyano-1-nitrosoguanidine in rat primary hepatocyte cultures.

Jensen DE, Belka GK, Dworkin C.

Biochem Pharmacol. 1997 May 9;53(9):1297-306.

PMID:
9214690
20.
21.

KAP-1, a novel corepressor for the highly conserved KRAB repression domain.

Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher FJ 3rd.

Genes Dev. 1996 Aug 15;10(16):2067-78.

24.

Transcription from TATA-less promoters: dihydrofolate reductase as a model.

Azizkhan JC, Jensen DE, Pierce AJ, Wade M.

Crit Rev Eukaryot Gene Expr. 1993;3(4):229-54. Review.

PMID:
8286846
25.

A conserved DNA structural control element modulates transcription of a mammalian gene.

Pierce AJ, Jambou RC, Jensen DE, Azizkhan JC.

Nucleic Acids Res. 1992 Dec 25;20(24):6583-7.

26.
27.

Glucose repression of the yeast ADH2 gene occurs through multiple mechanisms, including control of the protein synthesis of its transcriptional activator, ADR1.

Vallari RC, Cook WJ, Audino DC, Morgan MJ, Jensen DE, Laudano AP, Denis CL.

Mol Cell Biol. 1992 Apr;12(4):1663-73.

28.

Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.

Baldwin AS Jr, Azizkhan JC, Jensen DE, Beg AA, Coodly LR.

Mol Cell Biol. 1991 Oct;11(10):4943-51.

29.

Defective induction of Jun and Fos-related proteins in phorbol ester-resistant EL4 mouse thymoma cells.

Jensen DE, Frankis RC Jr, Sando JJ.

Oncogene. 1991 Jul;6(7):1219-25.

PMID:
1713662
30.

Protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells.

Homan EC, Jensen DE, Sando JJ.

J Biol Chem. 1991 Mar 25;266(9):5676-81.

31.

Microsomally-mediated denitrosation of nitrosoguanidinium compounds.

Jensen DE, Stelman GJ, Williams AW.

Carcinogenesis. 1990 Jul;11(7):1075-82.

PMID:
2372867
34.

Control of lymphokine production by protein kinase C.

Sando JJ, Homan EC, Jensen DE.

Prog Clin Biol Res. 1990;352:197-204.

PMID:
2402515
35.
36.

Inhibition of hemopoietic growth factor-induced proliferation by adenosine diphosphate-ribosylation inhibitors.

Colon-Otero G, Sando JJ, Sims JL, McGrath E, Jensen DE, Quesenberry PJ.

Blood. 1987 Sep;70(3):686-93.

37.

Absence of protein kinase C in nuclei of EL4 mouse thymoma cells.

Jensen DE, Sando JJ.

Cancer Res. 1987 Jul 15;47(14):3868-72.

38.

Effect of glutathione modulation using buthionine sulfoximine on DNA methylation by dimethylnitrosamine in the rat.

Tacchi AM, Jensen DE, Magee PN.

Biochem Pharmacol. 1987 Mar 15;36(6):881-5.

PMID:
3566787
39.

Species differences in blood-mediated nitrosocimetidine denitrosation.

Jensen DE, Stelman GJ, Spiegel A.

Cancer Res. 1987 Jan 15;47(2):353-9.

40.

Evidence for metabolism of N-nitrosoproline.

Fong LY, Jensen DE, Magee PN.

Chem Biol Interact. 1987;64(1-2):115-25.

PMID:
3121195
41.

Comparison of the acute toxicity of N-nitrosocimetidine with three structurally related carcinogens in the rat.

Ogiu T, Hard GC, Magee PN, Jensen DE.

Toxicol Pathol. 1986;14(4):395-403.

PMID:
3809892
42.

Modifications of circular DNA by photoalkylation.

Duker NJ, Jensen DE, Hart DM.

Radiat Res. 1985 Jul;103(1):114-21.

PMID:
4070556
43.

Quantitation of S-methylcysteine formed in O6-methylguanine-DNA:methyltransferase.

Ro JY, Jensen DE, Kim S.

Cancer Lett. 1984 Jun;23(2):213-21.

PMID:
6744245
44.
45.

Perturbations of enzymic uracil excision due to purine damage in DNA.

Duker NJ, Jensen DE, Hart DM, Fishbein DE.

Proc Natl Acad Sci U S A. 1982 Aug;79(16):4878-82.

46.

Involvement of superoxide in the interaction of 2,3-dichloro-1,4-naphthoquinone with mitochondrial membranes.

Pritsos CA, Jensen DE, Pisani D, Pardini RS.

Arch Biochem Biophys. 1982 Aug;217(1):98-109. No abstract available.

PMID:
6289757
47.

Deoxyribonucleic acid methylation in human cells exposed to nitrosocimetidine.

Jensen DE.

Biochem Pharmacol. 1981 Oct;30(20):2864-7. No abstract available.

PMID:
7317080
48.

Methylation of DNA by nitrosocimetidine in vitro.

Jensen DE, Magee PN.

Cancer Res. 1981 Jan;41(1):230-6. No abstract available.

49.
50.

Interaction of reactive intermediates with DNA.

Magee PN, Chu CK, Gombar CT, Jensen DE, Parchman LG.

Adv Exp Med Biol. 1981;136 Pt B:1335-47. No abstract available.

PMID:
6178271

Supplemental Content

Loading ...
Support Center